Ignite Creation Date:
2025-12-24 @ 10:47 PM
Ignite Modification Date:
2026-03-05 @ 6:01 AM
Study NCT ID:
NCT00832169
Status:
COMPLETED
Last Update Posted:
2009-04-28
First Post:
2009-01-29
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Investigation of Rate+Extent of Excretion of Radioactivity in Urine+Faeces After Oral Administration of [14C]AZD1386
Sponsor:
AstraZeneca
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
D5090C00015
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Rolf Karlsten, MD, PhD, Medical Science Director, Emerging Analgesia, Neuroscience
Old Organization:
AstraZeneca R&D Södertälje, Sweden